Cost-Effectiveness: From Genes to Healthcare System Reform

British health economist James Buchanan D.Phil. is skeptical that Geisinger Health System’s (Pa.) genomics project will prove to be cost-effective. But what about the cost-effectiveness of the whole U.S. health system? As a physician and resident of the southern reaches of Geisinger Health System’s catchment area in central Pennsylvania, I was intrigued by Dr. Buchanan’s … Continue reading Cost-Effectiveness: From Genes to Healthcare System Reform